Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Valacyclovir for Oral Mucositis in Head and Neck Radiotherapy
NCT07363031Phase 2Enrolling by invitation
- Sponsor
- Instituto Oncoclinicas
- Start
- Sep 2022
- Primary completion
- Jun 2026
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in oral mucositis (OM), sponsored by Instituto Oncoclinicas. Started Sep 2022; status: enrolling by invitation.
02
Drugs
valaciclovir
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07363031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363031.